| # | Title | Journal | Year | Citations |
|---|
| 1 | A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation | International Journal of Neuropsychopharmacology | 2011 | 892 |
| 2 | Oxidative stress in psychiatric disorders: evidence base and therapeutic implications | International Journal of Neuropsychopharmacology | 2008 | 821 |
| 3 | A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression | International Journal of Neuropsychopharmacology | 2008 | 781 |
| 4 | Blood BDNF concentrations reflect brain-tissue BDNF levels across species | International Journal of Neuropsychopharmacology | 2011 | 533 |
| 5 | A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia | International Journal of Neuropsychopharmacology | 2005 | 516 |
| 6 | Targeting acetylcholinesterase and butyrylcholinesterase in dementia | International Journal of Neuropsychopharmacology | 2006 | 492 |
| 7 | Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders | International Journal of Neuropsychopharmacology | 2011 | 462 |
| 8 | Dopamine System Dysregulation in Major Depressive Disorders | International Journal of Neuropsychopharmacology | 2017 | 444 |
| 9 | A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression | International Journal of Neuropsychopharmacology | 2008 | 442 |
| 10 | Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis | International Journal of Neuropsychopharmacology | 2002 | 427 |
| 11 | Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior | International Journal of Neuropsychopharmacology | 2016 | 419 |
| 12 | Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1) | International Journal of Neuropsychopharmacology | 2019 | 404 |
| 13 | Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder | International Journal of Neuropsychopharmacology | 2009 | 343 |
| 14 | A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults | International Journal of Neuropsychopharmacology | 2014 | 335 |
| 15 | Treatment non-response in OCD: methodological issues and operational definitions | International Journal of Neuropsychopharmacology | 2002 | 325 |
| 16 | Long-term symptomatic status of bipolar I vs. bipolar II disorders | International Journal of Neuropsychopharmacology | 2003 | 316 |
| 17 | Effects of antidepressants on the production of cytokines | International Journal of Neuropsychopharmacology | 2002 | 311 |
| 18 | Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease | International Journal of Neuropsychopharmacology | 2012 | 299 |
| 19 | Do we still believe in the dopamine hypothesis? New data bring new evidence | International Journal of Neuropsychopharmacology | 2004 | 295 |
| 20 | AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test | International Journal of Neuropsychopharmacology | 2004 | 290 |
| 21 | Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II) | International Journal of Neuropsychopharmacology | 2021 | 280 |
| 22 | Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders | International Journal of Neuropsychopharmacology | 2021 | 277 |
| 23 | The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans | International Journal of Neuropsychopharmacology | 2002 | 276 |
| 24 | Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive–compulsive disorder (OCD) and Tourette's syndrome (TS) | International Journal of Neuropsychopharmacology | 2006 | 275 |
| 25 | Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia | International Journal of Neuropsychopharmacology | 2003 | 272 |
| 26 | A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder | International Journal of Neuropsychopharmacology | 2009 | 267 |
| 27 | Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis | International Journal of Neuropsychopharmacology | 2013 | 257 |
| 28 | BDNF Release Is Required for the Behavioral Actions of Ketamine | International Journal of Neuropsychopharmacology | 2015 | 256 |
| 29 | Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons | International Journal of Neuropsychopharmacology | 2008 | 254 |
| 30 | Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions | International Journal of Neuropsychopharmacology | 2008 | 242 |
| 31 | Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects | International Journal of Neuropsychopharmacology | 2013 | 240 |
| 32 | Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial | International Journal of Neuropsychopharmacology | 2010 | 239 |
| 33 | Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid | International Journal of Neuropsychopharmacology | 2013 | 234 |
| 34 | The many faces of fatigue in major depressive disorder | International Journal of Neuropsychopharmacology | 2005 | 232 |
| 35 | Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology | International Journal of Neuropsychopharmacology | 2010 | 232 |
| 36 | NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation | International Journal of Neuropsychopharmacology | 2015 | 232 |
| 37 | A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression | International Journal of Neuropsychopharmacology | 2010 | 229 |
| 38 | The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system | International Journal of Neuropsychopharmacology | 2013 | 225 |
| 39 | A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department | International Journal of Neuropsychopharmacology | 2011 | 224 |
| 40 | Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive–compulsive disorder | International Journal of Neuropsychopharmacology | 2010 | 217 |
| 41 | Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders | International Journal of Neuropsychopharmacology | 2004 | 213 |
| 42 | Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene | International Journal of Neuropsychopharmacology | 2006 | 211 |
| 43 | Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review | International Journal of Neuropsychopharmacology | 2009 | 211 |
| 44 | Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia | International Journal of Neuropsychopharmacology | 2009 | 209 |
| 45 | Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis | International Journal of Neuropsychopharmacology | 2014 | 208 |
| 46 | Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder | International Journal of Neuropsychopharmacology | 2004 | 206 |
| 47 | QTc interval prolongation and antipsychotic drug treatments: focus on sertindole | International Journal of Neuropsychopharmacology | 2005 | 204 |
| 48 | Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635 | International Journal of Neuropsychopharmacology | 2001 | 202 |
| 49 | Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance | International Journal of Neuropsychopharmacology | 2016 | 202 |
| 50 | PM284. Agmatine prevents learning and memory deficit in repeated morphine withdrawal: Is it via glutamatergic system? | International Journal of Neuropsychopharmacology | 2016 | 200 |
